-
2024Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy, Nature Communications, 2024, 15 (1), pp.4175. ⟨10.1038/s41467-024-48269-2⟩.
-
2024Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy, Nature Communications.
-
2022Microfluidic dose-response platform to track the dynamics of drug response in single mycobacterial cells, Sci Rep 2022 Nov; 12(1): 19578.
-
2022RNase E and HupB dynamics foster mycobacterial cell homeostasis and fitness., iScience 2022 May; 25(5): 104233.
-
2021Listeriolysin S: A bacteriocin from Listeria monocytogenes that induces membrane permeabilization in a contact-dependent manner., Proc Natl Acad Sci U S A 2021 Oct; 118(40): .
-
2021Single-Cell Analysis of Mycobacteria Using Microfluidics and Time-Lapse Microscopy., Methods Mol Biol 2021 ; 2314(): 205-229.
-
20206,11-Dioxobenzo[f]pyrido[1,2-a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor., ACS Infect Dis 2020 11; 6(11): 3015-3025.
-
2020Delving Into the Functional Meaning of Phenotypic Variation in Mycobacterial Persistence: Who Benefits the Most From Programmed Death of Individual Cells?, Microbiol Insights 2020 ; 13(): 1178636120945304.
-
2020Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia., Front Microbiol 2020 ; 11(): 562.
-
2019Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress, EMBO J. 2019 Oct;:e101876.
-
2016Phenotypic Heterogeneity in Mycobacterium tuberculosis, Microbiol Spectrum 4(6):TBTB2-0021-2016.
-
2015Single-cell analysis of mycobacteria using microfluidics and time-lapse microscopy, Methods Mol. Biol. 2015;1285:241-56.
-
2014Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms, Cell Host Microbe 2015 Jan;17(1):32-46.
-
2013The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis, Appl. Microbiol. Biotechnol. 2013 Oct;97(20):8841-8.
-
2013A single-cell perspective on non-growing but metabolically active (NGMA) bacteria, Curr. Top. Microbiol. Immunol. 2013;374:135-61.
-
2010Decaprenylphosphoryl-β-D-ribose 2′-epimerase from Mycobacterium tuberculosis is a magic drug target, Curr. Med. Chem. 2010;17(27):3099-108.
-
2009Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis, Science 2009 May;324(5928):801-4.
-
2008Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system, Tuberculosis (Edinb) 2009 Jan;89(1):84-90.
-
2006LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis, Antimicrob. Agents Chemother. 2006 Dec;50(12):4044-52.
-
2006Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome, BMC Microbiol. 2006;6:66.